Trials / Sponsors / Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc.
Industry · 7 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | Observational Study of VYKAT™ XR in Patients With Prader-Willi Syndrome Prader-Willi Syndrome | — | 2025-11-26 |
| Active Not Recruiting | Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome Prader-Willi Syndrome | Phase 3 | 2023-01-31 |
| Unknown | An Open-Label Study of Diazoxide Choline in Patients With Genetic Obesities SH2B1 Deficiency Obesity, Obesity Associated With PCSK1 Mutation (rs6232 Variant), SIM1 Deficiency Obesity | Phase 2 | 2023-01-01 |
| Withdrawn | An Open-Label Study of DCCR Tablet in Patients With PWS Prader-Willi Syndrome | Phase 3 | 2019-10-01 |
| Completed | PWS Outcomes Assessment Study Prader-Willi Syndrome | — | 2019-07-15 |
| Completed | Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Prader-Willi Syndrome | Phase 3 | 2018-10-01 |
| Completed | A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome Prader-Willi Syndrome | Phase 3 | 2018-05-09 |